India lifts export ban of potential coronavirus drug after Trump threat

New Delhi to supply hydroxychloroquine to nations badly hit

KIRAN SHARMA, Nikkei staff writer

NEW DELHI -- India on Tuesday announced it would allow a limited export of an anti-malaria drug seen as helpful in the treatment of the new coronavirus, a day after U.S. President Donald Trump warned of retaliation if New Delhi did not heed his request to supply the medicine to his country.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.